Diabetology & Metabolic Diseases

It is a well-known fact that overweight (having a BMI of 30 or above) are at greater risk of developing metabolic chronic disorders like type 2 diabetes mellitus, insulin resistance. Accumulation of adipose tissue affects metabolism by secreting hormones, glycerol, and other substances including leptin, cytokines, adiponectin, and proinflammatory substances, and non-esterified fatty acids which are involved in the development of insulin resistance and disruption of fat metabolism. And the secretion of these substances will be increased leading to diabetes in obese individuals

 

  • Bariatric surgery
  • Malabsorption
  • Cardiovascular risk factors

Related Conference of Diabetology & Metabolic Diseases

February 24-25, 2025

18th International Conference on Childhood Obesity & Nutrition

London, UK
March 13-14, 2025

8th International Conference on Obesity and Chronic Diseases

Prague, Czech Republic
March 18-19, 2025

8th International Conference on Obesity and Diet Imbalance

Dubai, UAE
March 24-25, 2025

27th Global Obesity Meeting

London, UK
April 16-17, 2025

6th International Obesity, Diet and Weight Management Congress

Tokyo, Japan
April 17-18, 2025

23rd International Conference on Obesity, Diet Management & Nutrition

Madrid, Spain
April 17-18, 2025

5th World Summit on Obesity and Weight Management

Madrid, Spain
April 24-25, 2025

4th International Congress on Obesity and Nutritional Health

Vienna, Austria
June 02-03, 2025

21st Euro Obesity and Endocrinology Congress

Amsterdam, Netherlands

Diabetology & Metabolic Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in